Primary Progressive MS – Strong pipeline in progressive MS indicates paradigm shift in MS landscape Migraine – Launch of new molecules to further enhance treatment opportunities Secondary Progressive MS – Majority MS patients progress to SPMS indicating huge market potential Pharmascroll, a Research & Consulting Firm, launches 30+ reports in MS & Migraine indications Pharmascroll Research & Consulting and Market Publishers Ltd Sign Partnership Agreement Pharmascroll launches operations in Customized Pharmaceutical Marketing Research Pharmascroll launches Quality Focused Pharmaceutical Market Research services at affordable cost Secondary Progressive MS-Pharmascroll Report predicts increase in market activity in next 5-10 years Pharmascroll expands its Market Research offerings to multiple Disease Areas PPMS and SPMS: Epidemiology and Market Forecasts to 2030 Pharmascroll launches Market intelligence reports on disease indications Alzheimer’s: Disease Insights and Market Forecasts to 2024 by Pharmascroll Cystic Fibrosis: Disease Insights and Market Forecasts to 2024 by Pharmascroll COPD: Disease Insights and Market Forecasts to 2024 by Pharmascroll Asthma: Disease Insights and Market Forecasts to 2024 by Pharmascroll Parkinson’s: Disease Insights and Market Forecasts to 2024 by Pharmascroll Epilepsy: Disease Insights and Market Forecasts to 2024 by Pharmascroll Schizophrenia: Disease Insights & Market Forecasts to 2024 by Pharmascroll
